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In this data article, intracellular Ca2þ concentration ([Ca2þ]i) was
measured in isolated ventricular Wild Type (WT) and mdx cardi-
omyocytes in two different conditions: at rest and during the
application of an axial stretch. Using a carbon microﬁbers techni-
que, axial stretch was applied to mimic effects of physiological
conditions of ventricular ﬁlling. A study of cation entry with the
same experimental model and the manganese quenching method
reported (i) a constitutive cation entry in mdx cardiomyocytes and
(ii) the involvement of TRPV2 channels in axial-stretch dependant
cation entry, “Axial stretch-dependent cation entry in dystrophic
cardiomyopathy: involvement of several TRPs channels” (Aguettaz
et al., 2016) [1].
Here, the Ca2þ dye ﬂuo-8 was used for [Ca2þ]i measurement,
in both resting and stretching conditions, using a perfusion pro-
tocol starting initially with a calcium free Tyrode solution followed
by the perfusion of 1.8 mM Ca2þ Tyrode solution. The variation of
[Ca2þ]i was found higher in mdx cardiomyocytes.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.ceca.2016.01.001
fr (S. Sebille).
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 Protocol used in these experiments could activate Store-operated calcium channels (SOCs) and
stretch-activated calcium channels (SACs).
 This protocol can be used to investigate stretch-dependent calcium increases in cardiomyocytes
and other cells.
 The effects of SOCs and SACs inhibitors and activators may help to understand stretch-dependent
calcium increases.1. Data
These data mainly focus on describing intracellular calcium concentration ([Ca2þ]i) measured in
Wild Type (WT) and mdx cardiomyocytes in two different conditions: at rest and during the appli-
cation of an axial stretch. Calcium measurement was performed using the Ca2þ dye ﬂuo-8 and during
a perfusion protocol starting initially with a calcium free Tyrode solution followed by the perfusion of
1.8 mM Ca2þ Tyrode solution. In these conditions, [Ca2þ]i kinetics are described (Fig. 1A) and
amplitudes are compared in the presence of SACs inhibitors (Fig. 1B). The effect of TRPV2 inhibitors
(Fig. 2) and Probenecid (Fig. 3) is also described.2. Experimental design, materials and methods
2.1. Cells isolation, mechanical stimulation and Mn2þ-quenching experiments are described in [1]
2.1.1. Solutions and chemicals
Before experiments, cells were stored in culture medium containing Dulbecco's modiﬁed Eagle's
medium (DMEM – Lonza: 12-604F), complemented with 10 mg/mL insulin, 10 mg/mL gentamycin,
4 mM NaHCO3, 10 mM Hepes, 0.2% BSA and 12.5 mM blebbistatin (all from Sigma). During experi-
ments, cardiomyocytes were superfused with Tyrode solution containing 140 mM NaCl, 5.4 mM KCl,
1.8 mM CaCl2, 1.8 mM MgCl2, 10 mM Hepes and 11 mM glucose or with calcium-free Tyrode solution
containing 140 mM NaCl, 5.4 mM KCl, 1.8 mM MgCl2, 10 mM Hepes, 11 mM glucose, 1 g/L BSA and
20 mM Taurine.
Tranilast (Trn) was purchased from Calbiochem (53902-12-8), GsMTx-4 from Abcam (ab141871),
probenecid (Prb, P8761), Streptomycin sulfate (Strp, s9137) and 4-methyl-40-[3.5-bis(triﬂuoromethyl)-
1H-pyrazol-1-yl]-1.2.3-thiadiazole-5-carboxanilide (YM-58483, y4895) from Sigma, ryanodine from
Merck (15662-33-6), fura-2-AM (108964-32-5) and ﬂuo-8-AM (sc-362561) from Santa-Cruz.
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Fig. 1. (A) Representative recordings relative to ﬂuo-8 ﬂuorescence (expressed as DF/F0 (A. U.)) in resting WT (open circles) and
mdx (ﬁlled circles) and in stretched WT (open squares) and mdx (ﬁlled squares) during a superfusion protocol starting initially
with a calcium free Tyrode solution followed by the superfusion of 1.8 mM Ca2þ Tyrode solution. (B) Maximal amplitude of
ﬂuo-8 ﬂuorescence intensity in WT andmdx cardiomyocytes maintained in stretched condition with SACs inhibitors: cells were
incubated with 300 mM streptomycin (Strp, gray bars) or 2.5 mM GsMTx-4 (Black bars) for SACs inhibition and with 10 mM
nifedipine (vertical hatching) or 100 mM ryanodine (horizontal hatching) for EC coupling inhibition. Open bars represent the
control. Declined hatching represents rest (non-stretched). Measurements are represented as mean normalized ﬂuo 8 ﬂuor-
escence intensity7SEM. Rest (WT: n¼10 cells, N¼4 hearts; mdx: n¼12 cells, N¼4 hearts). stretch control (WT: n¼12 cells,
N¼4 hearts; mdx: n¼12 cells, N¼4 hearts). Strp (WT: n¼7 cells, N¼3 hearts; mdx: n¼6 cells, N¼3 hearts). Rest (WT: n¼10
cells, N¼4 hearts; mdx: n¼12 cells, N¼4 hearts). GsMTx-4 (WT: n¼5 cells, N¼3 hearts; mdx: n¼5 cells, N¼3 hearts). Nife-
dipine (WT: n¼5 cells, N¼4 hearts; mdx: n¼5 cells, N¼3 hearts). Ryanodine (WT: n¼9 cells, N¼4 hearts; mdx: n¼7 cells,
N¼4 hearts). * Symbol represents the statistical difference with control, ***Po0.001; ns, not signiﬁcant. # Symbol represents
the statistical difference between WT and mdx in stretched conditions. ###Po0.001.
E. Aguettaz et al. / Data in Brief 8 (2016) 1443–1447 14452.1.2. Intracellular calcium measurements using confocal microscopy
Cells were loaded at room temperature during 20 min with the single-wavelength calcium sen-
sitive probe ﬂuo-8-AM (6 mM) in Ca2þ-free Tyrode solution. Cells were stretched at 10% of the initial
sarcomere length before recording ﬂuorescence.
Fluorescence images were recorded by Confocal Laser Scanning Microscopy (CLSM) using a Bio-
Rad MRC 1024 (Bio-Rad Laboratories) equipped with a 15 mW Ar–Kr gas laser. Confocal unit was
attached to an inverted microscope (Olympus IX70) with a 60 water objective and ﬂuorescence
signal collection was performed through the control software Lasersharp 3.2 (Bio-Rad Laboratories).
Fluorophore was excited with the 488 nm line and the emitted ﬂuorescence was detected at 522 nm
(green ﬂuorescence). For analysis, ﬂuorescence was normalized (DF/F0) and calculated through IDL
software routines [2].
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Fig. 2. Maximal amplitude of ﬂuo 8 ﬂuorescence in WT and mdx cardiomyocytes maintained in stretching condition incubated
with TRPs inhibitors. Cells were incubated with TRPs blockers: antibody against an extracellular epitope of TRPV2 (Anti-TRPV2 :
dark gray bars), 100 mM tranilast (horizontal hatching) and YM-48483, inhibitor of TRPCs channels in stretched WT and mdx
cardiomyocytes. Open bars represent the control. Measurements are represented as mean normalized ﬂuo-8 ﬂuorescence
intensity7SEM. Control (WT: n¼10 cells, N¼4 hearts;mdx: n¼12 cells, N¼5 hearts). Anti-TRPV2 (WT: n¼6 cells, N¼4 hearts;
mdx: n¼6 cells, N¼4 hearts). Trn (WT: n¼6 cells, N¼3 hearts; mdx: n¼7 cells, N¼4 hearts). YM-48483 (WT: n¼8 cells, N¼4
hearts; mdx: n¼9 cells, N¼4 hearts). * Symbol represents the statistical difference with control *Po0.01; **Po0.005;
***Po0.001; and ns, no signiﬁcant.
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Fig. 3. Maximal amplitude of ﬂuo 8 ﬂuorescence in WT and mdx cardiomyocytes maintained in stretching condition incubated
with probenecid. Cells were incubated with 1 nM probenecid (Prb, black bars). Open bars represent the control and clear gray
bars mdx cardiomyocytes in resting conditions. Measurements are represented as mean normalized ﬂuo-8 ﬂuorescence
intensity7SEM. (C) Time between the beginning of the 1.8 mM Ca2þ perfusion and the start of the normalized ﬂuo-8 ﬂuor-
escence intensity increases. Measurements are represented as mean of the time to response onset (expressed in seconds)
7SEM. (D) Time between the start of the normalized ﬂuo-8 ﬂuorescence intensity increase and maximal amplitude. Mea-
surements are represented as mean of the time to reach maximal amplitude of ﬂuorescence signal (expressed in seconds)
7SEM. Control (WT: n¼8 cells, N¼3 hearts; mdx: n¼12 cells, N¼4 hearts). Prb (WT: n¼12 cells, N¼4 hearts; mdx: n¼8 cells,
N¼4 hearts). * Symbol represents the statistical differences with control. *Po0.01; **Po0.005; ***Po0.001; and ns, no sig-
niﬁcant. # Symbol represents the statistical difference between WT and mdx in stretched conditions. #Po0.01; and
###Po0.001. ns, no signiﬁcant.
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Data are presented as means7SEM, n is the number of cells. Differences were tested with t-test.
Po0.05 indicates a statistical signiﬁcant difference.Acknowledgments
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